Although treated mice still developed a productive infection with HIV-1, the mean plasma viral load was decreased about 30-fold relative to control vector-transduced mice and no CD4+ T cell loss was noted in treated mice for up to 55 days while CD4+ T cell loss was detected with the control vector. The gene discussed is CD4; the disease is infection.